Search

Author/Creator Lahner, Harald

1. Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study. (July 2021)

Authors:
Curigliano, Giuseppe; Martin, Miguel; Jhaveri, Komal; Beck, J.T.; Tortora, Giampaolo; Fazio, Nicola; Maur, Michela; Hubner, Richard A.; Lahner, Harald; Donnet, Valerie; Ajipa, Olga; Li, Zheng; Blumenstein, Lars; Andre, Fabrice
Journal:
European journal of cancer
Issue:
Volume 151(2021)
Page Start:
49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid 68Ga-DOTATOC PET/MRI. Issue 137 (April 2021)

Authors:
Bruckmann, Nils Martin; Rischpler, Christoph; Kirchner, Julian; Umutlu, Lale; Herrmann, Ken; Ingenwerth, Marc; Theurer, Sarah; Lahner, Harald; Antoch, Gerald; Sawicki, Lino M.
Journal:
European journal of radiology
Issue:
Issue 137(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study. Issue 10022 (5th March 2016)

Authors:
Yao, James C; Fazio, Nicola; Singh, Simron; Buzzoni, Roberto; Carnaghi, Carlo; Wolin, Edward; Tomasek, Jiri; Raderer, Markus; Lahner, Harald; Voi, Maurizio; Pacaud, Lida Bubuteishvili; Rouyrre, Nicolas; Sachs, Carolin; Valle, Juan W; Fave, Gianfranco Delle; Van Cutsem, Eric; Tesselaar, Margot; Sh...
Journal:
Lancet
Issue:
Volume 387:Issue 10022(2016)
Page Start:
968
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10 (October 2017)

Authors:
Pavel, Marianne E; Singh, Simron; Strosberg, Jonathan R; Bubuteishvili-Pacaud, Lida; Degtyarev, Evgeny; Neary, Maureen P; Carnaghi, Carlo; Tomasek, Jiri; Wolin, Edward; Raderer, Markus; Lahner, Harald; Valle, Juan W; Pommier, Rodney; Van Cutsem, Eric; Tesselaar, Margot E T; Fave, Gianfranco Delle...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 10(2017:Oct.)
Page Start:
1411
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Textural analysis of hybrid DOTATOC-PET/MRI and its association with histological grading in patients with liver metastases from neuroendocrine tumors. Issue 4 (April 2020)

Authors:
Weber, Manuel; Kessler, Lukas; Schaarschmidt, Benedikt; Fendler, Wolfgang Peter; Lahner, Harald; Antoch, Gerald; Umutlu, Lale; Herrmann, Ken; Rischpler, Christoph
Journal:
Nuclear medicine communications
Issue:
Volume 41:Issue 4(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗